APPLICATIONS PUBLISHED 8 MAY 2002

Published: 1-Dec-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Use of agonists of GABAB receptors and pharmaceutically accepatble derivatives thereof, in the therapy of maintaining nicotine abstinence in nicotine-dependent patients
    L Molteni & C Dei Fratelli Alitti Societa'Di Esercizio 1202727*

  • Peroxovanadium compounds as protein tyrosine phosphates (PTP) inhibitors; their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune response
    Universite Laval 1202728*

  • Phosphat etransport inhibitors
    SmithKline Beecham 1202729*

  • Use of EP4 receptor ligands in the treatment of neuropathic pain and colon cancer
    Glaxo Group 1202730*

  • Method for treating chronic pain using MEK inhibitors
    Warner-Lambert 1202731*

  • Method for treating chronic pain using MEK inhibitors
    Warner-Lambert 1202732*

  • 3(5)-amino-pyrazole derivatives, process for their preparation amd their use as antitumour agents
    Pharmacia Italia; Pharmacia & Upjohn 1202733*

  • 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as anti-tumour agents
    Pharmacia Italia; Pharmacia & Upjohn 1202734*

  • Methods of cancer treatment
    Procter & Gamble 1202735*

  • Nicotine in therapeutic angiogenesis and vasculogenesis
    The Board of Trustees of the Leland Stanford Junior University 1202736*

  • Antiviral therapy use of P-glycoprotein modulators
    Vanderbilt University 1202737*

  • Dihydropyrazine derivatives as NPY antagonists
    Bristol-Myers Squibb 1202738*

  • Rapid immediate release oral dosage form
    Shire Laboratories 1202739*

  • Method for producing chlorine dioxide using chemically impregnated expanded amorphous aluminium silicate
    Bio-Cide International 1202740*

  • Neurotropic virus transport
    Westmead Hospital; The University of Sydney 1202741*

  • Method and apparatus for the recovery of non-solvent type fills from gelatine capsules
    AB Technologies 1202742*

  • Fish serine proteases and their pharmaceutical and cosmetic use
    Bjarnson, Jon Bragi 1202743*

  • Production of RHPBGD and new therapeutic methods for treating patients with acute intermittent porphyria (AIP) and other porphyric diseases
    Hemebiotech 1202744*

  • Therapeutic and prophylactic compsns including catalytic biomimetic solids and methods to prepare and use them
    Henceforth Hibernia 1202745*

  • NSAID and EFGR kinase inhibitor containing compsn for the treatment or inhibition of colonic polyps and colorectal cancer
    American Cyanamid 1202746*

  • Sustained release drug dispersion delivery device
    Merck 1202747*

  • Polycation-based bioconjugates
    Szeg & Odblac 1202748*

  • Enzyme catalysed anti-infective therapeutic agents
    Newbiotics 1202749*

  • Method of treating HIV infection and related secondary infections thereof
    Burcoglu, Arsinur 1202750*

  • 2-dialkylaminoalkylbiphenyl derivatives
    Gruenenthal 1202953*

  • Novel aminobenzophenones
    Leo Pharmaceutical Products 1202954*

  • 1,4-substituted 4,4'-diaryl cyclohexanes
    SmithKline Beecham 1203955*

  • Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compsns containing same
    Biosalts 1202956*

  • Aminobenzophenones as inhibitors of Il-1beta and TNF-α
    Leo Pharmaceutical Products 1202957*

  • Dicyanatochalcones and method for the production thereof
    Lonza 1202958*

  • Indole derivatives, processes for their preparation, pharmaceutical compsns containing them, and their medicinal application
    Vernalis Research 1202965*

  • Piperidine alcohols
    Merck Patent 1202966*

  • Antibacterial agents
    British Biotech Pharmaceuticals 1202967*

  • You may also like